SARS-CoV-2 Infections in Vaccinated and Unvaccinated Populations in Camp Lemonnier, Djibouti, from April 2020 to January 2022.

Catherine E Arnold, Logan J Voegtly, Emily K Stefanov, Matthew R Lueder, Andrea E Luquette, Robin H Miller, Haven L Miner, Andrew J Bennett, Lindsay Glang, Tara N McGinnis, Kristie E Reisinger, Jae W Dugan, Michael A Mangat, Daniel J Silberger, Rebecca L Pavlicek, Chaselynn M Watters, Gregory K Rice, Francisco Malagon, Regina Z Cer, Stephen M Eggan, Kimberly A Bishop-Lilly
Author Information
  1. Catherine E Arnold: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA. ORCID
  2. Logan J Voegtly: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA. ORCID
  3. Emily K Stefanov: U.S. Naval Medical Research Unit No. 3 (NAMRU-3), 95030 Sigonella, Italy.
  4. Matthew R Lueder: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  5. Andrea E Luquette: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  6. Robin H Miller: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  7. Haven L Miner: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  8. Andrew J Bennett: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  9. Lindsay Glang: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  10. Tara N McGinnis: Expeditionary Medical Facility, CLDJ-HOA, Camp Lemonnier 09622, Djibouti.
  11. Kristie E Reisinger: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  12. Jae W Dugan: Expeditionary Medical Facility, CLDJ-HOA, Camp Lemonnier 09622, Djibouti.
  13. Michael A Mangat: U.S. Naval Medical Research Unit No. 3 (NAMRU-3), 95030 Sigonella, Italy.
  14. Daniel J Silberger: Navy Environmental Preventive Medicine Unit-Two, Norfolk, VA 23511, USA.
  15. Rebecca L Pavlicek: Expeditionary Medical Facility, CLDJ-HOA, Camp Lemonnier 09622, Djibouti. ORCID
  16. Chaselynn M Watters: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  17. Gregory K Rice: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  18. Francisco Malagon: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA. ORCID
  19. Regina Z Cer: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA.
  20. Stephen M Eggan: U.S. Naval Medical Research Unit No. 3 (NAMRU-3), 95030 Sigonella, Italy.
  21. Kimberly A Bishop-Lilly: Naval Medical Research Center, Fort Detrick, Frederick, MD 21702, USA. ORCID

Abstract

The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has highlighted the disparity between developed and developing countries for infectious disease surveillance and the sequencing of pathogen genomes. The majority of SARS-CoV-2 sequences published are from Europe, North America, and Asia. Between April 2020 and January 2022, 795 SARS-CoV-2-positive nares swabs from individuals in the U.S. Navy installation Camp Lemonnier, Djibouti, were collected, sequenced, and analyzed. In this study, we described the results of genomic sequencing and analysis for 589 samples, the first published viral sequences for Djibouti, including 196 cases of vaccine breakthrough infections. This study contributes to the knowledge base of circulating SARS-CoV-2 lineages in the under-sampled country of Djibouti, where only 716 total genome sequences are available at time of publication. Our analysis resulted in the detection of circulating variants of concern, mutations of interest in lineages in which those mutations are not common, and emerging spike mutations.

Keywords

References

  1. JAMA. 2020 Mar 17;323(11):1061-1069 [PMID: 32031570]
  2. Gene Rep. 2020 Jun;19:100682 [PMID: 32300673]
  3. Lancet. 2021 Jul 17;398(10296):213-222 [PMID: 34246358]
  4. Lancet. 2021 Feb 20;397(10275):671-681 [PMID: 33545094]
  5. N Engl J Med. 2022 Feb 10;386(6):599-601 [PMID: 35030645]
  6. Nature. 2021 Aug;596(7871):276-280 [PMID: 34237773]
  7. Cell Rep. 2022 May 17;39(7):110829 [PMID: 35550680]
  8. Mol Biol Evol. 2015 Jan;32(1):268-74 [PMID: 25371430]
  9. Lancet. 2021 Jun 26;397(10293):2461-2462 [PMID: 34139198]
  10. Nature. 2020 Mar;579(7798):270-273 [PMID: 32015507]
  11. Cell. 2021 Apr 29;184(9):2372-2383.e9 [PMID: 33743213]
  12. PLoS One. 2017 Oct 26;12(10):e0185056 [PMID: 29073143]
  13. PLoS One. 2013 Dec 05;8(12):e82089 [PMID: 24339995]
  14. Cell Host Microbe. 2021 Apr 14;29(4):522-528.e2 [PMID: 33789085]
  15. Nucleic Acids Res. 2002 Jul 15;30(14):3059-66 [PMID: 12136088]
  16. N Engl J Med. 2021 Jul 8;385(2):187-189 [PMID: 33951357]
  17. MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1922-1924 [PMID: 33332292]
  18. N Engl J Med. 2022 Feb 3;386(5):494-496 [PMID: 34965358]
  19. Biochem Biophys Res Commun. 2021 Jan 1;534:374-380 [PMID: 33272568]
  20. Science. 2021 Sep 03;373(6559):1142-1146 [PMID: 34315827]
  21. Front Med (Lausanne). 2022 Jan 27;8:836658 [PMID: 35155489]
  22. Science. 2021 Apr 9;372(6538): [PMID: 33658326]
  23. MMWR Morb Mortal Wkly Rep. 2021 Jan 01;69(5152):1653-1656 [PMID: 33382675]
  24. N Engl J Med. 2021 Sep 23;385(13):1172-1183 [PMID: 34192426]
  25. Virus Evol. 2021 Jul 30;7(2):veab064 [PMID: 34527285]
  26. Nat Rev Drug Discov. 2021 Oct;20(10):728 [PMID: 34489598]
  27. Arch Virol. 2021 Sep;166(9):2541-2549 [PMID: 34258664]
  28. MMWR Morb Mortal Wkly Rep. 2021 Mar 05;70(9):329-332 [PMID: 33661860]
  29. ACS Appl Bio Mater. 2021 Feb 15;4(2):1178-1190 [PMID: 34192244]
  30. Pharmacotherapy. 2020 Aug;40(8):857-868 [PMID: 32643218]
  31. Nat Med. 2022 Mar;28(3):490-495 [PMID: 35046573]
  32. Nat Microbiol. 2020 Apr;5(4):536-544 [PMID: 32123347]
  33. Nat Commun. 2020 Mar 27;11(1):1620 [PMID: 32221306]
  34. Sci Rep. 2021 Feb 25;11(1):4659 [PMID: 33633229]
  35. Glob Chall. 2017 Jan 10;1(1):33-46 [PMID: 31565258]
  36. Lancet. 2021 Mar 6;397(10277):881-891 [PMID: 33617777]
  37. PLoS Pathog. 2021 Aug 5;17(8):e1009772 [PMID: 34352039]
  38. Bioinformatics. 2009 Aug 15;25(16):2078-9 [PMID: 19505943]
  39. Genome Biol. 2019 Jan 8;20(1):8 [PMID: 30621750]
  40. mBio. 2014 Jun 17;5(3):e01360-14 [PMID: 24939889]
  41. Nature. 2021 May;593(7857):136-141 [PMID: 33706364]
  42. Nature. 2021 May;593(7857):130-135 [PMID: 33684923]
  43. Nat Med. 2021 Dec;27(12):2136-2143 [PMID: 34728831]

MeSH Term

COVID-19
Djibouti
Genome, Viral
Humans
Mutation
SARS-CoV-2
Vaccines

Chemicals

Vaccines

Word Cloud

Created with Highcharts 10.0.0SARS-CoV-2DjiboutisequencesmutationssurveillancesequencingpublishedApril2020January2022CampLemonnierstudyanalysiscirculatinglineagesglobalpandemiccausedsevereacuterespiratorysyndromecoronavirus2highlighteddisparitydevelopeddevelopingcountriesinfectiousdiseasepathogengenomesmajorityEuropeNorthAmericaAsia795SARS-CoV-2-positivenaresswabsindividualsUSNavyinstallationcollectedsequencedanalyzeddescribedresultsgenomic589samplesfirstviralincluding196casesvaccinebreakthroughinfectionscontributesknowledgebaseunder-sampledcountry716totalgenomeavailabletimepublicationresulteddetectionvariantsconcerninterestcommonemergingspikeInfectionsVaccinatedUnvaccinatedPopulationsbioinformaticsgenomics

Similar Articles

Cited By